To explore the mechanisms of HDGF-driven gefitinib resistance, we determined the gefitinib resistance-associated proteins p-Akt and p-ERK in NSCLC cells (Fig. 5A) and mouse tumor tissues (Fig. 5B). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.